Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001558370-23-016172
Filing Date
2023-09-29
Accepted
2023-09-29 17:02:24
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tmb-20230929x424b5.htm 424B5 1287697
2 GRAPHIC tmb-20230929x424b5001.jpg GRAPHIC 10036
3 GRAPHIC tmb-20230929x424b5002.jpg GRAPHIC 9047
4 GRAPHIC tmb-20230929x424b5003.jpg GRAPHIC 11611
  Complete submission text file 0001558370-23-016172.txt   1331653
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-254363 | Film No.: 231296505
SIC: 2834 Pharmaceutical Preparations